Grifols S.A. ADR (GRFS)
NASDAQ
Closed
Oct 9, 2026
Day's Range
7.4452 wk Range
6.96Overview - GRFS - Grifols S.A. ADR
Key Statistics
Valuation
Enterprise Value
23.81B
P/E (Trailing)
‪9.74‬
P/E (Forward)
‪5.06‬
PEG Ratio
‪0.06‬
Price / Sales (TTM)
‪0.67‬
Price / Book
‪1.59‬
EV / EBITDA
‪12.88‬
Profitability
Gross Margin
‪37.62%‬
Profit Margin
‪6.09%‬
Operating Margin
‪15.90%‬
Return on Assets
‪4.23%‬
Return on Equity
‪6.93%‬
Ownership
Shares Outstanding
680.58M
Float
836.39M
Held by Insiders
‪0.00%‬
Held by Institutions
‪57.02%‬
Price stats
Beta
‪1.19‬
50-Day Avg
‪7.72‬
200-Day Avg
‪8.16‬
Dividends
Payout Ratio
‪36.83%‬
Frequency
Annual
Analyst Consensus
2 analysts
Average price target
‪$ 10.87‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - GRFS - Grifols S.A. ADR
Peers - GRFS - Grifols S.A. ADR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NASDAQ.
- GRFSNASDAQGrifols S.A. ADR4.97BMarket Cap-31.46%52-week change9.75P/E (Trailing)‪6.09%‬Profit Margin
- AZNNASDAQAstraZeneca PLC243.33BMarket Cap-8.97%52-week change23.59P/E (Trailing)‪17.02%‬Profit Margin
- AMGNNASDAQAmgen Inc.217.89BMarket Cap+27.02%52-week change25.05P/E (Trailing)‪22.95%‬Profit Margin
- GILDNASDAQGilead Sciences, Inc.179.47BMarket Cap+21.53%52-week change17.87P/E (Trailing)‪-10.63%‬Profit Margin
- SNYNASDAQSanofi ADR95.65BMarket Cap-24.52%52-week change21.01P/E (Trailing)‪8.09%‬Profit Margin
- ROPNASDAQRoper Technologies Inc.35.05BMarket Cap-41.10%52-week change14.55P/E (Trailing)‪30.24%‬Profit Margin
- BIIBNASDAQBiogen Inc.32.48BMarket Cap+29.94%52-week change39.06P/E (Trailing)‪8.32%‬Profit Margin
Profile Summary - GRFS - Grifols S.A. ADR
About
Grifols S.A. ADR is a healthcare and biotechnology asset representing Grifols’ U.S. depositary shares. Grifols is a global specialty plasma therapeutics company focused on the research, development, manufacturing, and distribution of plasma-derived medicines and related biopharmaceutical products. Its core activities…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
